Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesLaboratory/PathologyProvidence Organic Acid Testing Coverage | OpenPay…
    Ask Trek AI about this page
    CurrentProvidence Health PlanPolicy 254

    Organic Acid Testing

    Customize your policy alerts

    Sign up for Providence Health Plan Policy 254 alerts

    Get alerted when Policy 254 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical necessity and coverage of organic acid testing for Providence commercial members, including testing for organic acid disorders, suspected metabolic disorders, and suspected vitamin B12 deficiency. It applies to Providence Health Plan, Providence Health Assurance, and Providence Plan Partners.

    Policy Summary
    PayerProvidence Health Plan
    PolicyOrganic Acid Testing
    Policy CodePolicy 254
    Change TypeAnnual reviewno material change
    Effective DateNov 1, 2026
    Last ReviewOct 1, 2026
    Next Review DateOct 1, 2027
    Key ActionFor an unlisted code submitted for a potentially covered service, obtain prior authorization to help avoid a post-service denial.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    3Covered indication categories
    20

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Non-covered symptom examples
    5Non-covered multi-acid panels
    CommercialPlan product
    3Organic acid CPT codes
    12 monthsNewborn threshold

    Medical Necessity Criteria

    Covered Indications

    Screening for organic acid disorders may be considered medically necessary when ANY of the following indications is met:

    ONE of the following

    • The member is a newborn or infant up to 1 year of age.<= 12 months
    • The member has a metabolic disorder (see Billing Guidelines).
    • Methylmalonic acid testing is performed for suspicion of vitamin B12 deficiency.

    Not Medically Necessary Testing

    Organic acid testing is considered not medically necessary when the covered-indication criteria are not met, including but not limited to testing for:

    Any of the following indications without a qualifying covered indication

    • Fatigue
    • Sleep abnormalities
    • Mood changes
    • Blood sugar dysregulation
    • Weight gain
    • Nausea
    • Multiple chemical sensitivity
    • Bloating

    Multi-Analyte Organic Acid Panels

    Panels that include multiple organic acids are considered not medically necessary, including but not limited to:

    Any of the following multi-analyte panels

    • Genova Diagnostics® Metabolic Analysis Profile (Organic Acids)
    • Genova Diagnostics® Organix® Basic Profile
    • Genova Diagnostics® Organix® Comprehensive Profile
    • Genova Diagnostics® Organix® Dysbiosis Profile
    • The Great Plains Laboratory, Inc. Organic Acid Test

    General Medical-Necessity Criteria

    Organic acid testing is generally not medically necessary, with exceptions for newborns and patients with suspected metabolic disorders.

    Testing may be considered medically necessary when ONE of the following applies

    • The patient is a newborn or infant up to 1 year of age.<= 12 months
    • The patient has a suspected metabolic disorder.

    Non-Newborn Diagnosis-Code Criteria

    Excluding newborns 12 months of age or younger, CPT 83918, 83919, and 83921 may be considered medically necessary only when billed with a qualifying diagnosis code.

    ALL of the following

    • The patient is not a newborn or infant 12 months of age or younger.> 12 months
    • The billed code is CPT 83918, 83919, or 83921.
    • The claim includes a diagnosis code in the range E00-E89 or one of the following codes: K909, Z8639, Z13228, Z8349, or G9341.

    Methylmalonic Acid Testing for Potential B12 Deficiency

    CPT 83921 may be considered medically necessary for methylmalonic acid testing for potential vitamin B12 deficiency when the suspected deficiency is supported by one of the following diagnosis codes:

    ONE of the following diagnosis codes

    • D51.0 — Vitamin B12 deficiency anemia due to intrinsic factor deficiency
    • D51.1 — Selective vitamin B12 malabsorption with proteinuria
    • D51.2 — Transcobalamin II deficiency
    • D51.3 — Other dietary vitamin B12 deficiency anemias
    • D51.8 — Other vitamin B12 deficiency anemias

    For adults, an organic-acid testing claim associated only with a metabolic-disorder diagnosis is not medically necessary unless the patient is a newborn or infant up to 1 year of age or there is a suspected metabolic disorder. Clinical practice guidelines recommend organic acid testing to diagnose metabolic disorders in adults; however, well-designed clinical studies have not shown that testing improves overall health outcomes when used to diagnose metabolic disorders in adults.

    When no specific CPT or HCPCS code exists for a panel, the provider must bill an unlisted code under Coding Policy 30.0. Individual tests in the panel must not be billed separately as if performed individually; doing so misrepresents the services performed and is inconsistent with CPT and CMS guidelines. CMS identified unbundling laboratory panels as an example of fraudulent billing in a Healthcare Fraud Prevention Partnership white paper published in May 2018.

    Testing is not medically necessary when the member is not a newborn or infant up to 1 year of age, does not have a metabolic disorder or suspected metabolic disorder, and is not receiving methylmalonic acid testing for suspected vitamin B12 deficiency.

    The following named multi-organic-acid panels are considered not medically necessary: Genova Diagnostics® Metabolic Analysis Profile (Organic Acids); Genova Diagnostics® Organix® Basic Profile; Genova Diagnostics® Organix® Comprehensive Profile; Genova Diagnostics® Organix® Dysbiosis Profile; and The Great Plains Laboratory, Inc. Organic Acid Test.

    Organic acid testing is generally not medically necessary because well-designed clinical studies have not shown improvement in overall health outcomes when testing is used to diagnose metabolic disorders in adults. Testing is considered not medically necessary except for newborns and patients with suspected metabolic disorders, subject to the applicable coverage and coding criteria.

    For non-newborn patients, CPT 83918 (organic acids, total, quantitative, each specimen), CPT 83919 (organic acids, qualitative, each specimen), and CPT 83921 (organic acid, single, quantitative) may be considered medically necessary only when billed with a diagnosis code in the range E00-E89 or one of the following codes: K909, Z8639, Z13228, Z8349, or G9341. When other diagnosis codes are billed, these CPT codes will deny as not medically necessary. CPT 83921 may also be considered medically necessary for methylmalonic acid testing for potential vitamin B12 deficiency when billed with D51.0, D51.1, D51.2, D51.3, D51.8, or D51.9.

    Billing and Diagnosis Codes

    Organic Acid Testing CPT CodesCPTCovered
    83918Organic acids; total, quantitative, each specimen.
    83919Organic acids; qualitative, each specimen.
    83921Organic acid, single, quantitative.
    Unlisted CodeCPT
    81599Unlisted multianalyte assay with algorithmic analysis
    Diagnosis Codes Supporting Organic Acid TestingICD-10Covered
    E00-E89Diagnosis code range accepted for organic acid testing medical-necessity consideration in patients excluding newborns 12 months of age or younger.
    K909Specified diagnosis code accepted for organic acid testing medical-necessity consideration.
    Z8639Specified diagnosis code accepted for organic acid testing medical-necessity consideration.
    Z13228Specified diagnosis code accepted for organic acid testing medical-necessity consideration.
    Z8349Specified diagnosis code accepted for organic acid testing medical-necessity consideration.
    G9341Specified diagnosis code accepted for organic acid testing medical-necessity consideration.
    Diagnosis Codes for Methylmalonic Acid Testing in Potential B12 DeficiencyICD-10Covered
    D51.0Diagnosis code supporting CPT 83921 methylmalonic acid testing for potential vitamin B12 deficiency.
    D51.1Diagnosis code supporting CPT 83921 methylmalonic acid testing for potential vitamin B12 deficiency.
    D51.2Diagnosis code supporting CPT 83921 methylmalonic acid testing for potential vitamin B12 deficiency.
    D51.3Diagnosis code supporting CPT 83921 methylmalonic acid testing for potential vitamin B12 deficiency.
    D51.8Diagnosis code supporting CPT 83921 methylmalonic acid testing for potential vitamin B12 deficiency.
    D51.9Diagnosis code supporting CPT 83921 methylmalonic acid testing for potential vitamin B12 deficiency.
    Newborn age
    Age threshold12 months of age or younger
    Policy designationNewborns
    Coding applicationThe diagnosis-code restriction for CPT 83918, 83919, and 83921 excludes newborns 12 months of age or younger.

    Provider and Billing Guidance

    Prior Authorization

    Prior Authorization for Potentially Covered Unlisted Services

    Prior authorization is recommended for potentially covered unlisted services to support claim-level review of medical necessity, correct coding, and pricing and to avoid post-service denial.

    • All unlisted codes are reviewed at the claim level.
    • Unlisted services submitted for non-covered services addressed in this policy will be denied as not covered.
    Denial Risk

    Qualifying Indication Required

    Organic acid testing may be considered medically necessary only when a qualifying indication is present. Testing is not medically necessary when the coverage criteria are not met.

    • Newborns and infants up to 1 year of age.

    Clinical Background

    Organic acids are metabolic intermediates produced through central energy production, detoxification, neurotransmitter breakdown, and intestinal microbial pathways. Organic acid disorders are rare inherited enzyme deficiencies that can cause toxic organic acid accumulation and may present early in life with vomiting, seizures, lethargy, muscle irritability, or hypothermia. Organic acid testing is used primarily to diagnose these disorders and, in some settings, to assess proposed metabolic or detoxification-related abnormalities.

    Key Terms

    Organic acids
    DefinitionMetabolic intermediates produced in pathways of central energy production, detoxification, neurotransmitter breakdown, or intestinal microbial activity.
    Central energy productionOrganic acids are produced in pathways of central energy production.
    Other pathwaysOrganic acids are also produced through detoxification, neurotransmitter breakdown, and intestinal microbial activity.
    Organic acid disorders
    DefinitionRare inherited conditions caused by enzyme deficiencies that result in a buildup of toxic organic acid intermediates.
    Underlying mechanismEnzyme deficiencies limit the body's ability to break down certain amino acids.

    Qualifying Covered Indications

    Screening for Organic Acid Disorders in Newborns and Infants Up to 1 Year of Age

    Screening for organic acid disorders may be considered medically necessary for newborns and infants up to 1 year of age.

    Newborn or infant screening: The member is a newborn or infant up to 1 year of age.up to 1 year of age

    Testing in newborns is standard of care and is encompassed in expanded newborn screening performed within the first week of life.

    Testing for Members With Metabolic Disorders or Suspected Metabolic Disorders

    Organic acid testing may be considered medically necessary when the member has a metabolic disorder or is suspected of having one.

    Metabolic-disorder indication: The member has a metabolic disorder or a suspected metabolic disorder.

    Suspected metabolic disorder is an exception to the general position that organic acid testing is not medically necessary.

    Non-Covered Services and Indications

    Organic acid testing is not covered as medically necessary when a qualifying indication is absent, including testing requested for fatigue, sleep abnormalities, mood changes, blood sugar dysregulation, weight gain, nausea, multiple chemical sensitivity, bloating, distention, joint pain, gas, reflux, autoimmune disorders, dermatitis, depression, anxiety, cancer, inflammation, headaches, or early aging.

    Testing for non-qualifying symptoms or conditions remains not medically necessary, including the examples listed in this policy. In addition, multi-analyte panels containing multiple organic acids are not medically necessary, including the named Genova Diagnostics, Organix, Great Plains Laboratory, and similar panels.

    Testing to diagnose a metabolic disorder in an adult is not medically necessary when the patient does not have a suspected metabolic disorder and is not a newborn.

    Policy Summary
    PayerProvidence Health Plan
    PolicyOrganic Acid Testing
    Policy CodePolicy 254
    Change TypeAnnual reviewno material change
    Effective DateNov 1, 2026
    Last ReviewOct 1, 2026
    Next Review DateOct 1, 2027
    Key ActionFor an unlisted code submitted for a potentially covered service, obtain prior authorization to help avoid a post-service denial.
    SourceLink
    On This Page
    Medical Necessity CriteriaBilling and Diagnosis CodesProvider and Billing GuidanceClinical BackgroundKey TermsQualifying Covered IndicationsNon-Covered Services and Indications
    Distention
  1. Joint pain
  2. Gas
  3. Reflux
  4. Autoimmune disorders
  5. Dermatitis
  6. Depression
  7. Anxiety
  8. Cancer
  9. Inflammation
  10. Headaches
  11. Early aging
  12. D51.9 — Vitamin B12 deficiency anemia, unspecified
  13. Members with metabolic disorders.
  14. Methylmalonic acid testing for suspicion of B12 deficiency.
  15. Denial Risk

    Multi-Organic-Acid Panels Not Covered

    Panels that include multiple organic acids are considered not medically necessary, including the following named multi-analyte panels.

    • Genova Diagnostics® Metabolic Analysis Profile (Organic Acids).
    • Genova Diagnostics® Organix® Basic Profile.
    • Genova Diagnostics® Organix® Comprehensive Profile.
    • Genova Diagnostics® Organix® Dysbiosis Profile.
    • The Great Plains Laboratory, Inc. Organic Acid Test.
    Denial Risk

    Non-Qualifying Symptoms or Conditions

    Testing is not medically necessary when supported only by non-qualifying symptoms or conditions rather than a policy-listed indication.

    • Fatigue; sleep abnormalities; mood changes; blood sugar dysregulation; weight gain; nausea; multiple chemical sensitivity.
    • Bloating; distention; joint pain; gas; reflux; autoimmune disorders; dermatitis.
    • Depression; anxiety; cancer; inflammation; headaches; early aging.
    Denial Risk

    Use Supported Diagnosis Coding

    For members other than newborns 12 months of age or younger, CPT codes 83918, 83919, and 83921 may be considered medically necessary only when billed with an eligible diagnosis code. Otherwise, the codes will deny as not medically necessary.

    • Eligible diagnosis range: E00-E89.
    • Additional eligible diagnosis codes: K909, Z8639, Z13228, Z8349, and G9341.
    • CPT 83921 may be considered medically necessary for methylmalonic acid testing for potential B12 deficiency when billed with D51.0, D51.1, D51.2, D51.3, D51.8, or D51.9.
    Billing Rule

    Unlisted-Code Review and Denial

    Unlisted services are reviewed for medical necessity, correct coding, and pricing at the claim level. Potentially covered unlisted services should be submitted with prior authorization recommended; unlisted services for non-covered services addressed by this policy will be denied as not covered.

    • When no specific CPT or HCPCS code exists for a panel, bill the applicable unlisted code, such as CPT 81599 when appropriate.
    • Prior authorization is recommended for potentially covered unlisted services to avoid post-service denial.
    • Do not use an unlisted code to seek coverage for services identified as not covered by this policy.
    Billing Rule

    Panel Unbundling Prohibited

    When no specific CPT or HCPCS code exists for a panel, the provider must bill using an unlisted code. Do not bill the individual tests in the panel separately as if they were performed individually; this is unbundling and may constitute misrepresentation of services and fraudulent billing.

    • Bill the panel with the applicable unlisted code when no specific panel code exists.
    • Do not separately bill individual panel tests.
    • Claims remain subject to NCCI procedure-to-procedure bundling edits and CMS medically unlikely edits (MUEs).
    Typical onsetOrganic acid disorders may present in the first week of life.
    Organic acid testing
    DefinitionLaboratory testing used to diagnose organic acid disorders.
    Metabolic applicationsTesting is also used to identify metabolic blocks or problems with detoxification.
    Other proposed usesTesting is also utilized to assess gut dysbiosis, or microbial imbalance, and oxidative stress.

    Methylmalonic Acid Testing for Suspicion of Vitamin B12 Deficiency

    Methylmalonic acid testing may be considered medically necessary when performed for suspicion of vitamin B12 deficiency.

    Suspected vitamin B12 deficiency: Methylmalonic acid testing is performed for suspicion of vitamin B12 deficiency using CPT 83921.

    Newborn Testing

    Organic acid testing is an exception to the general not-medically-necessary position when used in newborns.

    Newborn exception: The patient is a newborn and the organic acid testing is used for newborn screening or evaluation.

    Organic acid testing is otherwise considered not medically necessary except for newborns and patients with suspected metabolic disorders.

    Suspected Metabolic Disorder

    Organic acid testing may be medically necessary for patients with suspected metabolic disorders.

    Suspected metabolic disorder: The patient is suspected of having a metabolic disorder.

    Clinical practice guidelines recommend organic acid testing to diagnose metabolic disorders in adults, although evidence of improved overall health outcomes is limited.

    Potential Vitamin B12 Deficiency Evaluated With Methylmalonic Acid Testing

    CPT 83921 may be considered medically necessary for methylmalonic acid testing when the claim includes a qualifying vitamin B12-deficiency diagnosis.

    CPT and diagnosis requirement: The service is billed with CPT 83921 and diagnosis code D51.0, D51.1, D51.2, D51.3, D51.8, or D51.9.

    These diagnosis codes support methylmalonic acid testing for potential vitamin B12 deficiency.